Market Insights & Analysis


Analyst Ratings Coverage: Morgan Stanley & Co. maintained their "Underweight" rating, adjusting the target price from USD 27.5 to USD 27 per share. HSBC Securities (USA) initiated coverage on Alcoa with a "Hold" rating and a target price of USD 29 on December 7, 2023. AA Ratings by Stock Target Advisor Alcoa Stock...

AA

238 Analyst Ratings Dec 7th Name Symbol Analyst Action Rating Closing Price Target Price Agilent Technologies Inc A Goldman Sachs & Co. Maintains Buy 128.91 145 Alcoa Corp AA HSBC Securities (USA) Initiates Coverage...

Top Analyst Downgrades: Dec7th Name Symbol Analyst Action Rating Closing Price Target Price STA Analyst Rating Alkami Technology Inc ALKT Stephens Downgrades Equal-Weight 22.31 24 Strong Buy Cerevel Therapeutics Holdings...

Analyst Upgrades Name Symbol Analyst Action Rating Closing Price Target Price STA Analyst Rating Athabasca Oil Corp ATH:CA TD Securities Upgrades Buy 3.36 4.5 Strong Buy Athabasca Oil...

Top Stock Highlights: China's Export Growth Signals Economic Recovery: China's exports experienced growth for the first time in six months in November, surpassing economists' expectations. This positive development suggests that the country's manufacturing sector, the second-largest in the world, may be recovering from a challenging period of...

AbbVie Inc. (ABBV: NYE) is said to be closing in on a significant deal to acquire Cerevel Therapeutics Holdings Inc. in a deal worth approximately $8.7 billion. Cerevel Therapeutics (CERE: NSD) is a drug developer specializing in neurological conditions such as Parkinson's.   ABBV Ratings by Stock Target...

Biggest Gainers
Price 1 Week Change
USD 6.10
-0.54 (-9.94%)
USD 37.38
+0.16 (+0.53%)
USD 24.13
-0.62 (-3.05%)
USD 15.24
+0.18 (+1.46%)
USD 27.49
-0.13 (-0.56%)
Biggest Losers
Price 1 Week Change
USD 44.30
-1.14 (-2.13%)
USD 14.75
+0.49 (+3.02%)
USD 82.92
+1.51 (+1.66%)
USD 6.50
-0.31 (-4.12%)
USD 7.68
-0.72 (-7.79%)
Biggest Gainers
Price 1 Week Change
CAD 14.29
-0.03 (-0.24%)
CAD 8.17
-0.02 (-0.27%)
CAD 4.52
-0.01 (-0.25%)
CAD 14.35
+0.19 (+1.48%)
CAD 19.94
-0.34 (-1.84%)
Biggest Losers
Price 1 Week Change
CAD 45.58
+0.23 (+0.46%)
CAD 11.66
+0.08 (+0.66%)
CAD 60.86
+0.30 (+0.47%)
CAD 22.21
-0.09 (-0.39%)
CAD 3.01
-0.10 (-3.08%)
Biggest Gainers
Price 1 Week Change
GBX 1,588.00
-22.00 (-1.45%)
GBX 265.10
+0.80 (+0.32%)
GBX 570.80
-4.40 (-0.80%)
GBX 70.46
+0.93 (+1.38%)
GBX 1,650.00
+0.00 (+0.00%)
Biggest Losers
Price 1 Week Change
GBX 220.50
+5.80 (+2.49%)
GBX 991.60
+6.00 (+0.58%)
GBX 743.00
+19.40 (+2.56%)
GBX 1,789.00
-14.00 (-0.75%)
GBX 619.00
-1.50 (-0.24%)
Biggest Gainers
Price 1 Week Change
INR 2,515.90
-45.30 (-2.02%)
INR 3,045.00
+44.80 (+1.71%)
INR 525.50
+4.35 (+0.95%)
INR 456.90
+9.80 (+2.41%)
INR 4,232.20
-27.55 (-0.70%)
Biggest Losers
Price 1 Week Change
INR 1,470.60
-13.50 (-0.84%)
INR 744.40
-2.05 (-0.26%)
INR 195.80
+4.15 (+2.08%)
INR 101.25
+0.00 (+0.00%)
INR 44.30
+0.15 (+0.33%)
Ad

From the Investment Vault

Curated Articles based on your interest

AIG Ratings by Stock Target Advisor Analyst Ratings Coverage AIG Inc:  Wells Fargo & Company (Rank#11), one of the leading financial institutions, has recently reiterated its analysis and rating for AIG. Let's delve into the details and explore the implications of their assessment: Wells Fargo & Company...

AIG

Analyst Ratings Coverage Onex Corp, a leading private equity firm has had it's coverage updated by analysts who have just updated their ratings and target prices for the company's stock. STA Research maintains a "Buy" rating for Onex Corp, with a target price of CAD 70. This indicates that STA Research believes the stock has potential for...

Today's Analyst Ratings Coverage Cormark Securities, a prominent financial services firm, has downgraded Air Canada's stock rating to "Underperform" and set a target price of CAD 23.75. This rating suggests that Cormark Securities believes the stock will underperform compared to the overall market or industry. The lower target price implies a...

Apple iPhone Sales Drop 18 Percent KeyBanc Capital Markets recently released data indicating a decline in Apple iPhone sales by 18%. While this may raise concerns among shareholders, KeyBanc advises them to look beyond these short-term challenges and focus on the company's robust long-term fundamentals. Despite the drop in iPhone sales, Nispel...

Shares of SoFi Technologies (SOFI) have received a unanimous "Buy" rating from twelve different brokerage firms, according to a report by STA Research Ratings. The company has garnered six "Buy" ratings and six "Hold" ratings from analysts. These assessments have resulted in an average 12-month target price of $7.45.   Recent comments...

TransAlta Corp Stock Forecast: According to a stock forecast from 10 analysts, the average target price for TransAlta Corp over the next 12 months is CAD 15.34. The analysts' average rating for the company is Strong Buy. However, Stock Target Advisor's own analysis of TransAlta Corp suggests a Neutral stance, based on 7 positive signals and 6...

Gevo Inc. (GEVO), an energy company specializing in renewable chemicals and advanced biofuels, is projected to achieve earnings of $0.73 per share for the fiscal year 2025, according to a recent research report by HC Wainwright. This estimate represents a downward revision from their previous forecast of $0.88 per share. The consensus estimate for...

Enovix Co. (ENVX) experienced a substantial surge in short interest during the month of April. The number of shorted shares reached 29,460,000, indicating a growth of 13.9% compared to the total of 25,860,000 shares reported on April 15th. (https://www.udenar.edu.co/) Currently, 25.3% of the company’s stock is being sold short. With an...

Seres Therapeutics, a biotechnology company, is expected to report a loss of ($1.49) per share for the fiscal year 2024, according to a forecast by Chardan Capital, a leading equity research firm. The consensus estimate for the company's full-year earnings is ($1.06) per share. Various analysts have been covering Seres Therapeutics MCRB and...

Analyst Coverage Change Today's latest analyst ratings release on Manulife's stock: Scotia Capital has lowered their target price to CAD 32 on 05/12/2023. RBC has increased their target price and rated the stock as Sector Perform with a target of CAD 30 on 05/12/2023. Cormark Securities has downgraded their target price to CAD 28 on...